SF3B1 mutations in myelodysplastic syndromes: Clinical associations and prognostic implications

F. Damm; F. Thol; O. Kosmider; S. Kade; P. Löffeld; F. Dreyfus; A. Stamatoullas-Bastard; A. Tanguy-Schmidt; O. Beyne-Rauzy; S. De Botton; A. Guerci-Bresler; G. Göhring; B. Schlegelberger; A. Ganser; O. A. Bernard; M. Fontenay; M. Heuser

doi:10.1038/leu.2011.321

SF3B1 mutations in myelodysplastic syndromes: Clinical associations and prognostic implications

F. Damm, F. Thol, O. Kosmider, S. Kade, P. Löffeld, F. Dreyfus, A. Stamatoullas-Bastard, A. Tanguy-Schmidt, O. Beyne-Rauzy, S. De Botton, A. Guerci-Bresler, G. Göhring, B. Schlegelberger, A. Ganser, O. A. Bernard, M. Fontenay, M. Heuser

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

84 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	1137-1140
Nombre de pages	4
journal	Leukemia
Volume	26
Numéro de publication	5
Les DOIs	https://doi.org/10.1038/leu.2011.321
état	Publié - 1 mai 2012

Accès au document

10.1038/leu.2011.321

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Damm, F., Thol, F., Kosmider, O., Kade, S., Löffeld, P., Dreyfus, F., Stamatoullas-Bastard, A., Tanguy-Schmidt, A., Beyne-Rauzy, O., De Botton, S., Guerci-Bresler, A., Göhring, G., Schlegelberger, B., Ganser, A., Bernard, O. A., Fontenay, M., & Heuser, M. (2012). SF3B1 mutations in myelodysplastic syndromes: Clinical associations and prognostic implications. Leukemia, 26(5), 1137-1140. https://doi.org/10.1038/leu.2011.321

@article{97620385ae3e47b4a6197f0d64a6b45c,

title = "SF3B1 mutations in myelodysplastic syndromes: Clinical associations and prognostic implications",

author = "F. Damm and F. Thol and O. Kosmider and S. Kade and P. L{\"o}ffeld and F. Dreyfus and A. Stamatoullas-Bastard and A. Tanguy-Schmidt and O. Beyne-Rauzy and {De Botton}, S. and A. Guerci-Bresler and G. G{\"o}hring and B. Schlegelberger and A. Ganser and Bernard, {O. A.} and M. Fontenay and M. Heuser",

note = "Funding Information: This study was supported by the Hannelore-Munke Fellowship and grant #109686 by the Deutsche Krebshilfe awarded to FD; HiLF grant from Hannover Medical School awarded to FT; association {\textquoteleft}Laurette Fugain{\textquoteright} (OAB and FD); grant {\textquoteleft}Direction de la recherche clinique AP-HP (PHRC MDS-04){\textquoteright} and INCa translational research 2008 awarded to FM; grant No. DJCLS R 10/22 from the Deutsche-Jos{\'e}-Carreras Leuk{\"a}mie-Stiftung e.V.; grant No. 109003 from the Deutsche Krebshilfe e.V; and grant No. M 47.1 from the H. W. & J. Hector Stiftung. We thank the investigators of the German myelodysplastic study group and the Groupe Francophone des My{\'e}lodysplasies (Dr B Slama, Avignon; Dr Gardembas, Angers; Dr Dib, Angers; Dr Rose, Lille; Dr Cheze, Caen; Dr Ame, Strasbourg; Dr Gyan, Tours) for including patients, and Martin Wichmann, Kerstin G{\"o}hrlich, Lamya Slama, Gaelle Herledan and Julien Brard for technical assistance.",

year = "2012",

month = may,

day = "1",

doi = "10.1038/leu.2011.321",

language = "English",

volume = "26",

pages = "1137--1140",

journal = "Leukemia",

issn = "0887-6924",

number = "5",

}

Damm, F, Thol, F, Kosmider, O, Kade, S, Löffeld, P, Dreyfus, F, Stamatoullas-Bastard, A, Tanguy-Schmidt, A, Beyne-Rauzy, O, De Botton, S, Guerci-Bresler, A, Göhring, G, Schlegelberger, B, Ganser, A, Bernard, OA, Fontenay, M & Heuser, M 2012, 'SF3B1 mutations in myelodysplastic syndromes: Clinical associations and prognostic implications', Leukemia, VOL. 26, Numéro 5, p. 1137-1140. https://doi.org/10.1038/leu.2011.321

TY - JOUR

T1 - SF3B1 mutations in myelodysplastic syndromes

T2 - Clinical associations and prognostic implications

AU - Damm, F.

AU - Thol, F.

AU - Kosmider, O.

AU - Kade, S.

AU - Löffeld, P.

AU - Dreyfus, F.

AU - Stamatoullas-Bastard, A.

AU - Tanguy-Schmidt, A.

AU - Beyne-Rauzy, O.

AU - De Botton, S.

AU - Guerci-Bresler, A.

AU - Göhring, G.

AU - Schlegelberger, B.

AU - Ganser, A.

AU - Bernard, O. A.

AU - Fontenay, M.

AU - Heuser, M.

N1 - Funding Information: This study was supported by the Hannelore-Munke Fellowship and grant #109686 by the Deutsche Krebshilfe awarded to FD; HiLF grant from Hannover Medical School awarded to FT; association ‘Laurette Fugain’ (OAB and FD); grant ‘Direction de la recherche clinique AP-HP (PHRC MDS-04)’ and INCa translational research 2008 awarded to FM; grant No. DJCLS R 10/22 from the Deutsche-José-Carreras Leukämie-Stiftung e.V.; grant No. 109003 from the Deutsche Krebshilfe e.V; and grant No. M 47.1 from the H. W. & J. Hector Stiftung. We thank the investigators of the German myelodysplastic study group and the Groupe Francophone des Myélodysplasies (Dr B Slama, Avignon; Dr Gardembas, Angers; Dr Dib, Angers; Dr Rose, Lille; Dr Cheze, Caen; Dr Ame, Strasbourg; Dr Gyan, Tours) for including patients, and Martin Wichmann, Kerstin Göhrlich, Lamya Slama, Gaelle Herledan and Julien Brard for technical assistance.

PY - 2012/5/1

Y1 - 2012/5/1

UR - http://www.scopus.com/inward/record.url?scp=84860767817&partnerID=8YFLogxK

U2 - 10.1038/leu.2011.321

DO - 10.1038/leu.2011.321

M3 - Letter

C2 - 22064355

AN - SCOPUS:84860767817

SN - 0887-6924

VL - 26

SP - 1137

EP - 1140

JO - Leukemia

JF - Leukemia

IS - 5

ER -